Results 1 to 10 of about 2,647 (131)

Synovial fluid leukocytes as diagnostic marker in periprosthetic shoulder infection [PDF]

JSES International
Background: Limited data exist regarding the diagnostic accuracy of synovial fluid leukocyte count (SFLC) in diagnosing periprosthetic shoulder infection (PSI).
Stefan Köppe, Daniel Karczewski, MD, Rony-Orijit Dey Hazra, MD, Alp Paksoy, MD, Agahan Hayta, MD, Doruk Akgün, MD   +5 more
doaj   +3 more sources

EPNS/SFNP guideline on the anticoagulant treatment of cerebral sinovenous thrombosis in children and neonates

European Journal of Paediatric Neurology, 2012
Anticoagulation of cerebral sinovenous thrombosis (CSVT) is recommended in adults and has been also approved in the paediatric setting. Some controversies remain however between the existing paediatric professional consensus, notably about its use in children with intra-cranial haemorrhage and in neonates.
Axel Lebas, Stéphane Chabrier, Joel Fluss   +2 more
exaly   +5 more sources

Traitement anticoagulant des thromboses veineuses cérébrales de l’enfant et du nouveau-né. Les recommandations de la Société française de neurologie pédiatrique (SFNP)

Archives De Pediatrie, 2011
Anticoagulation is recommended in the acute phase of cerebral venous thrombosis in adults, then for 3-12 months. In children, 2 consensus reports published in 2008 also recommend use of anticoagulants, whereas conclusions diverge for newborns. These consensus reports are based on observational studies, authors' experience, and comparisons with adult ...
Stéphane Chabrier, Manoëlle Kossorotoff   +1 more
exaly   +3 more sources

Oral Bioavailability Evaluation of Celastrol-Encapsulated Silk Fibroin Nanoparticles Using an Optimized LC-MS/MS Method

Molecules, 2020
Celastrol (CL), a compound isolated from Tripterygium wilfordii, possesses various bioactivities such as antitumor, anti-inflammatory and anti-obesity effects.
Shuyu Zhan, Amy Paik, Felicia Onyeabor, Baoyue Ding, Sunil Prabhu, Jeffrey Wang   +5 more
doaj   +2 more sources

Optimization of Preparation and Preclinical Pharmacokinetics of Celastrol-Encapsulated Silk Fibroin Nanoparticles in the Rat

Molecules, 2019
Celastrol (CL), a bioactive compound isolated from Tripterygium wilfordii, has demonstrated bioactivities against a variety of diseases including cancer and obesity.
Felicia Onyeabor, Amy Paik, Surya Kovvasu, Baoyue Ding, Jelissa Lin, Md Arif Wahid, Sunil Prabhu, Guru Betageri, Jeffrey Wang   +8 more
doaj   +2 more sources

Biodegradable Nanocomposites Developed from PLA/PCL Blends and Silk Fibroin Nanoparticles: Study on the Microstructure, Thermal Behavior, Crystallinity and Performance

Journal of Polymers and the Environment, 2020
Recently, the use of natural materials has grown in the plastics industry. In this study, silk fibroin nanoparticle (SFNP) was successfully synthesized from silk fibroin (SF) and analyzed by Fourier-transform infrared spectroscopy (FT-IR), X-ray ...
Masoud Dadras Chomachayi, Azam Jalali-Arani, Freddys R Beltran   +2 more
exaly   +3 more sources

The effect of silk fibroin nanoparticles on the morphology, rheology, dynamic mechanical properties, and toughness of poly(lactic acid)/poly(ε‐caprolactone) nanocomposite

Journal of Applied Polymer Science, 2020
The silk fibroin nanoparticles (SFNPs) were extracted from silkworm cocoons and used as a nanofiller in poly(lactic acid) (PLA)/poly(ε-caprolactone) (PCL) blend.
Masoud Dadras Chomachayi, Azam Jalali-Arani, J Martinez Urreaga   +2 more
exaly   +2 more sources

Nature Is a Valuable Source for the Biosynthesis of Nanoparticles and Their Effects on the Treatment of Osteomyelitis. [PDF]

J Cell Mol Med
ABSTRACT Infection is still one of the biggest threats to global health. Today, treating infections such as osteomyelitis is challenging due to the rise in drug‐resistant and biofilm‐forming pathogens. Therefore, researchers worldwide are seeking new ways to combat these infections.
Sadeghifar AR, Farsinejad A, Satarzadeh N, Shahabi A, Sadeghi Dousari A.   +4 more
europepmc   +2 more sources

Le risque de décès chez l’enfant avec épilepsie : recommandations de prévention et de prise en charge de la Société française de neurologie pédiatrique (SFNP)

Perfectionnement En Pédiatrie, 2021
Resume Si la prise en compte du risque de deces est bien integree a la prise en charge des patients adultes avec epilepsie, le sujet est plus souvent passe sous silence en pediatrie. Cette difference d’attitude s’explique par le manque de donnees dans la litterature, l’idee que le risque de deces est inferieur chez l’enfant, la crainte que l’anxiete ...
Dorothee Ville, S Napuri
exaly   +2 more sources

BPNS SFNP Joint meeting 2020 [PDF]

Journal of the Peripheral Nervous System, 2020
openaire   +2 more sources